Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Tab Title Description
The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are:* What are the frequency of uveitis subtypes in children?* What are clinical and demographic characteristics overall and within each type of uveitis?Participants will complete one enrollment visit with their doctor. Participants with uveitis onset \<6 months from enrollment date will also partake in a 12 month chart review.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:* Age: * Incident cases (onset ≤ 6 months) \<17 years * Established cases (onset \> 6 months) \<18 years* Diagnosis of any type of uveitis (infectious or noninfectious) in any location except traumatic and post-operative uveitis.* Active or inactive uveitis with any treatment status (current / prior / none \[but under surveillance\]).Exclusion Criteria:* Bilateral uveitis with differing etiologies* Traumatic uveitis* Post-operative uveitis* Immediate family member (spouse, biological or legal guardian, child, sibling, parent) who is an investigative site personnel directly affiliated with this study or who is an employee of JAEB Center for Health Research.* Ocular disease related to Retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, Juvenile xanthogranuloma (JXG), or leukemia/malignancy within the eye.
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic principal investigator
Contact us for the latest status
Bridgette Halder
5074222780
Contact Ushalder.bridgette@mayo.edu